_11zon.jpg)
Most parents know that breast milk is good for babies. Fewer know exactly why, and fewer still have heard of human milk oligosaccharides, or HMOs, which are now understood to be one of the most important and biologically active parts of breast milk.
HMOs in breast milk are not a single compound. They are a large, complex family of carbohydrates; researchers have identified over 200 different structures, and they are the third most abundant solid in human milk after lactose and fat. Yet babies can't digest them directly. So what are they actually doing?
The answer is more involved than most people expect, because HMO composition in breast milk changes as the baby grows, adjusting to what the baby's gut and immune system need at each stage.
HMOs are complex sugar molecules that are found only in human breast milk. The baby’s upper digestive system and the small intestine pass them through. Once they reach the large intestine, HMOs feed specific good bacteria, such as Bifidobacterium species.
By feeding these good gut bacteria, HMOs help shape the baby’s gut microbiome in the first months of life. This can have a lasting effect on immune development, allergy risk, metabolic health, and general protection against infections. In addition to feeding the gut bacteria, HMOs also:
HMOs are far more important than just their prebiotic properties. Their multiple biological roles are believed to reach beyond the gut.
In the first 2-3 days after birth, the breasts produce colostrum, small volumes of thick, yellowish early milk. Colostrum is packed with bioactive compounds, and HMO content is at its highest at this point.
This high early concentration makes sense. The newborn gut is being colonised for the first time. The right bacteria need to establish themselves quickly, and the gut lining needs protection from pathogens. The HMOs in colostrum are particularly suited to these two jobs; the types most potent at sealing the gut and driving early beneficial bacterial colonisation are the ones found at the highest levels in those first few days.

HMO composition does not stay fixed. It shifts as weeks and months pass.
The first weeks: As milk changes from colostrum to mature milk, total HMO concentration drops somewhat from the colostrum peak, but diversity remains high. The gut microbiome is still being established, and HMOs continue to feed and support the Bifidobacterium species that dominate a healthy infant gut in the early months.
Two to three months: By this point, the HMO profile has shifted. Some HMO concentrations drop, and some may increase. At this stage, the gut microbiome is mature. So, the HMOs start to maintain the microbial community and also focus on immune regulation.
Six months onwards: This is the time when solids are introduced, and the gut environment changes. New foods feed a wide range of gut bacteria, and the microbiome diversifies. HMOs at this stage match what the changing gut needs.
1 year onwards: If you are breastfeeding beyond 1 year, HMO concentrations are much lower than during early lactation. Still, the milk contains a range of HMOs that can help support the immune system. At this stage, the role shifts from gut colonisation to ongoing immune protection.
Several factors influence how HMOs change during lactation:
The baby's age and stage of development appear to be the primary drivers. Milk composition adapts to match what the baby needs at each stage, suggesting a biological communication between mother and baby that is not yet fully mapped but is clearly precise.
Genetics plays a major role in determining which HMOs a mother produces. One of the most studied genetic differences is whether a woman makes a specific HMO called 2'-fucosyllactose (2'-FL), determined by the FUT2, or Secretor, gene. Around 20% of women are non-secretors and do not make 2'-FL at all. These mothers still produce many other HMOs, but the baby's gut microbiome looks different as a result.
Gestational age at birth also affects the HMO profile. Mothers who deliver prematurely produce milk with a different HMO composition than mothers who deliver at term, weighted towards types thought to be especially protective for the preterm gut.
Maternal diet and gut health affect HMOs less than other milk components. Still, emerging evidence suggests the mother's own gut microbiome composition may influence which HMOs are produced.

Understanding that HMO composition in breast milk shifts over time reinforces one important point: breast milk is not a fixed food. It is a living fluid that adjusts to the baby's changing needs in ways that are genuinely difficult to replicate.
This is one reason the WHO and Indian Academy of Paediatrics recommend exclusive breastfeeding for the first six months and continued breastfeeding alongside complementary foods for at least two years. The HMO profile at six months is different from that at one month because the baby's needs have changed.
For parents who cannot breastfeed or choose to use formula, some products now include synthetic versions of specific HMOs, most commonly 2'-FL and lacto-N-neotetraose (LNnT). These add some prebiotic benefit, but no formula product has yet matched the full range and complexity of naturally occurring human milk oligosaccharides.
HMOs in breast milk are not a fixed ingredient; they are a shifting, adapting system that responds to the baby's age and developmental needs across the entire breastfeeding journey. From the high concentrations of early colostrum through the gradual changes of mature lactation, human milk oligosaccharides are one of the clearest examples of how precisely breast milk adjusts to meet the growing baby's needs.

Want to consult the Best Gynecologists in India? Please find the links below.
Want to consult the Best Maternity Packages in India? Please find the links below.
Yes. HMO composition in breast milk changes as the baby grows. Colostrum has the highest HMO concentration, with types suited to initial gut colonisation. As lactation continues, the HMO profile shifts: some types reduce while others become more prominent, reflecting the changing needs of the baby's gut microbiome and immune system. This ongoing adaptation is one reason breast milk is uniquely suited to the infant at every stage of development.
Yes, in multiple ways. Fat, protein, and carbohydrate content all shift over lactation, and HMO composition changes alongside them. HMOs change during lactation from the high concentrations of early colostrum through the changes of mature milk at 2-3 months and beyond. These changes are not random; they match what the baby's gut, immune system, and microbiome need at each point in development.
In the first days, colostrum is high in HMOs, especially types with antimicrobial and gut-protective properties important for the newborn. As milk matures, total HMO concentration drops slightly, but diversity remains high. By 2-3 months, the HMO profile shifts further as the gut microbiome settles. At six months, when solids are introduced, HMO types shift again to match the changing gut environment and expanding microbiome.
Not in the same amounts or proportions. Human milk oligosaccharides are present throughout breastfeeding, but the specific types and their concentrations change considerably from colostrum through early, mid, and late lactation. Some HMOs prominent in early milk reduce over time. A mother's genetic Secretor status also means certain HMOs, like 2'-FL, are absent from around 20% of mothers' milk entirely, regardless of how long they breastfeed.